[HIV: a guide on management of seropositive patients].
Olivier
D
D
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D004338:Drug Combinations; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D006679:HIV Seropositivity / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D061466:Lopinavir; D009748:Nutrition Disorders / Q000517:prevention & control; D010346:Patient Care Management; D010817:Physician-Patient Relations; D011744:Pyrimidinones / Q000627:therapeutic use; D011788:Quality of Life; D019438:Ritonavir / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D019380:Anti-HIV Agents; D004338:Drug Combinations; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D061466:Lopinavir; D017291:Clarithromycin; D019438:Ritonavir